Sharemaestro Newsreel

Establishment Labs Holdings Inc. Stock 12‑Month Price Target Raised to $101.22, Implies 11% Upside

Nine analysts have raised the average 12-month price target for Establishment Labs Holdings Inc. (ESTA) stock from $97.22 to $101.22, representing an approximately 11% potential upside based on the August 5th closing price. The consensus rating for the stock remains a "Buy," with 8 …

STERIS plc (STE) Stock Price, News, Quote & History

This article provides a comprehensive overview of STERIS plc (STE) stock, including its current price, dividend information, key financial metrics, and company profile. It details the company's segments in Healthcare, Applied Sterilization Technologies, and Life Sciences, and offers performance benchmarks against the S&P 500, …

Medtronic gets CE mark for ablation to treat ventricular tachycardia

Medtronic has received an expanded CE mark for its Affera mapping and ablation system and Sphere-9 catheter to treat ventricular arrhythmias, including ventricular tachycardia. The Sphere-9 catheter also recently received breakthrough device designation from the FDA, acknowledging the need for more effective treatments for …

GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical, Inc. GMED used its second-quarter 2026 call to emphasize margin execution and continued spine share gains, while management flagged Nevro and Enabling Technologies as risks within the second-half outlook. GMED's second-quarter Non-GAAP EPS of $1.34 beat the $1.12 Zacks Consensus Estimate. Revenues …

Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Intelligent Bio Solutions Inc (INBS) has an earnings forecast score of 10.00, ranking 1st in the Biotechnology & Medical Research industry. Analysts have set an average price target of $12.00, with a "Strong Buy" rating from the single analyst covering the stock, indicating a …

Enovis Corporation Stock 12‑Month Price Target Cut to $41.25, Implies 37% Upside

The average 12-month price target for Enovis Corporation (ENOV) stock has been lowered from $41.58 to $41.25 by analysts, despite this reduction, the new target still suggests a potential upside of approximately 37% based on the August 5th closing price. The consensus rating for …

Lucid Diagnostics Inc (LUCD) Stock News Today

This page provides an overview of Lucid Diagnostics Inc (LUCD) stock news, including current trading information and a note that more news is coming soon. The stock is currently trading at 0.953 USD, down 0.05%, with a market cap of 124.88M. The article is …

electroCore, Inc. Q2 2026: Revenue $9.45M, Net income (loss) $(3.06M) — 10-Q Summary

electroCore, Inc. reported its Q2 2026 financial results, with revenue reaching $9.45 million, marking a 28% increase year-over-year, and a net loss of $3.06 million, an improvement from the previous year. The revenue growth was primarily driven by prescription gammaCore and Quell Fibromyalgia sales …

Butterfly Network (NYSE: BFLY) gains 11.8% beneficial owner in FMR LLC

FMR LLC has reported an 11.8% beneficial ownership stake in Butterfly Network (NYSE: BFLY), acquiring 28,952,296.89 shares of Class A common stock. Abigail P. Johnson is also listed with sole dispositive power over these shares through FMR LLC. The Schedule 13G filing indicates this …

Rapid Micro Biosystems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Rapid Micro Biosystems, Inc. announced its earnings for the second quarter and six months ending June 30, 2026. For the second quarter, revenue increased to USD 8.05 million from USD 7.26 million year-over-year, but the net loss widened to USD 12.92 million from USD …

Tandem Diabetes Care seeing early benefits of new pay-as-you-go model

iRhythm Technologies (NASDAQ:IRTC) Sees Unusually-High Trading Volume Following Strong Earnings

CVRx Shares Slide on Sales View Cut

CVRx shares dropped after the company announced a cut in its sales guidance. This adjustment in financial outlook indicates potential challenges or revised expectations for the company's performance.

Delcath Systems, Inc. Stock 12‑Month Price Target Raised to $24.17, Implies 91% Upside

Delcath Systems, Inc. (DCTH) has seen its average 12-month price target raised to $24.17 by 6 analysts, up from $22.5, with individual forecasts ranging from $21 to $30. This updated target suggests a potential upside of approximately 91% from its August 5th closing price. …

Rapid Micro Biosystems earnings missed by $0.02, revenue topped estimates

Sera Prognostics Inc (SERA) Stock News Today

QuidelOrtho stock drops after Q2 results (QDEL:NASDAQ)

QuidelOrtho Corporation (QDEL) stock dropped over 25% following its Q2 2026 earnings report, despite reporting better-than-expected financials. The decline was attributed to the company lowering its full-year outlook, citing significant market headwinds, especially in China. QuidelOrtho's quarterly revenue reached $630.9M, showing approximately 3% year-over-year …

Establishment Labs Holdings Releases Q2 2026 Financial Results

Establishment Labs Holdings reported Q2 2026 financial results, missing analyst expectations for earnings with a net loss of $0.39 per share, despite strong revenue growth of 31.7% to $67.5 million. The company showed progress towards breakeven with a narrowed loss per share year-over-year and …

Establishment Labs Holdings Inc (ESTA) (Q2 2026) Earnings Call Highlights: U.S. Sales Surge 140. ...

Establishment Labs Holdings Inc (ESTA) reported strong Q2 2026 results, with total revenue up 31.7% year-over-year to $67.5 million, significantly driven by a 140.9% surge in U.S. sales to $24.7 million. The company achieved positive Adjusted EBITDA of $3.7 million, a substantial improvement from …

CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution Disclosures

Johnson Fistel, PLLP is investigating CVRx, Inc. (CVRX) after the company significantly lowered its full-year revenue guidance to $58 million–$60 million, down from $63 million–$67 million. This reduction is attributed to challenges with sales-force execution, high turnover, and difficulties with onboarding and training new …

PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert for Insulet Corporation (NASDAQ: PODD) investors who purchased shares between February 21, 2025, and May 26, 2026. The lawsuit alleges that Insulet's manufacturing controls were defective, leading to a risk of safety violations. Investors are …

ITOC DEADLINE: The Gross Law Firm Reminds iTonic Holdings

The Gross Law Firm has issued a notice to shareholders of iTonic Holdings Ltd. (NASDAQ: ITOC) regarding an upcoming securities class action deadline. Investors who purchased shares between September 5, 2024, and July 29, 2025, are encouraged to contact the firm, as the company …

STERIS plc (STE) Stock News Today

This page provides current stock information for STERIS plc (STE), including its market price, market capitalization, P/E ratio, and recent performance. It indicates that more news and earnings updates for the company will be available soon. The platform, TradingKey, offers general investment information and …

Sera Prognostics Inc (SERA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Clearpoint Neuro Inc (CLPT) Stock News Today

Insulet (PODD) Is Down 15.9% After Cutting 2026 Revenue Guidance on Type 2 Retention Strains

Insulet Corporation (PODD) saw its stock drop 21.9% after cutting its 2026 revenue outlook due to weaker retention and utilization among Type 2 diabetes users, despite strong overall Omnipod growth. The company reported Q2 2026 sales of US$801.7 million and net income of US$95.0 …

Earnings Preview: Brainsway to Report Financial Results Pre-market on August 12

Brainsway (BWAY.US) is scheduled to release its financial results pre-market on August 12 ET. Analysts estimate the company to report Q2 2026 revenue of USD16.54 million, a 30.95% year-over-year increase, with EPS estimated at USD0.073, up 193.2% year-over-year. The accounting standard used for these …

ElectroCore 2Q Loss $3.06M >ECOR

ElectroCore reported a second-quarter loss of $3.06 million. Further details regarding the company's financial performance or future outlook were not provided in this brief announcement.

What To Expect From CeriBell Inc (CBLL) Q2 2026 Earnings

CeriBell Inc (CBLL) is scheduled to release its Q2 2026 earnings on August 10, 2026, with revenue expected at $27.29 million and an estimated earnings per share of -$0.47. Analysts project full-year 2026 revenue to be $113.98 million and earnings per share to be …

Earnings To Watch: Quanterix Corp (QTRX) Q2 2026 -- GF Value Sees 253% Upside

Quanterix Corp (QTRX) is set to release its Q2 2026 earnings on August 10, 2026, with revenue estimated at $37.46 million and an expected loss of $0.40 per share. While full-year 2026 revenue estimates have slightly declined, earnings estimates for 2027 have also seen …

Rapid Micro Biosystems Inc (RPID) Stock News Today

Needham cuts iRhythm Technologies stock price target on lower multiple

Needham has lowered its price target for iRhythm Technologies (NASDAQ:IRTC) to $192 from $255, while maintaining a Buy rating. The adjustment comes despite iRhythm exceeding Q2 2026 revenue expectations and raising its full-year guidance, partly due to the acquisition of VitalConnect which is expected …

Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Apyx Medical Corp (APYX), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 5 analysts, the stock has a "Buy" trend with an average price target of $5.00. The company's expected revenue …

Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Alphatec Holdings recently reported its second-quarter earnings, leading to analysts updating their price targets and earnings forecasts for the company. While sales beat expectations, earnings per share missed targets, resulting in a slight reduction in the consensus price target. The article examines the sentiment …

Apyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary

Apyx Medical Corp (APYX) reported its 2026 quarterly results, with revenue increasing to $13.88M from $11.37M year-over-year. The company posted a net loss of ($3.24M) and a diluted loss per share of ($0.07), showing an improvement from the prior year. This performance was largely …

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates